This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A container closure system consists of all the packaging components that contain and protect a pharmaceutical product. They provide specific guidance on packaging requirements for closed closure integrity (CCI) and general integrity testing. Container Closure Systems. Container closure systems are highly regulated by health agencies.
Recruiters know that finding top talent in the lifesciences is challenging. To meet this growing need, Xtalks has launched Xtalks Job Search , a fully customizable tool to help bring lifescience employers and job seekers together. Here are 10 reasons why Xtalks Job Search is the best place to post your next vacancy.
Softbox, a leading global innovator and provider of temperature control packaging systems and thermal covers for the lifescience and logistics industries, has announced the appointment of Charlie Nicholson as Softbox’s new Global CFO.
The editorial team also discussed Bayer’s announcement of its commitment to 100 percent green packaging for its consumer products by 2030. Bayer’s most popular consumer products like Aspirin, Aleve and Claritin will all have green packaging by the target year, which will also include recycling information that is consumer friendly.
A £650 million investment package by AstraZeneca in the UK has been held up by Chancellor Jeremy Hunt as a “vote of confidence” in the country’s lifesciences sector.
AvKARE, a generics pharmaceutical manufacturer based in Pulaski, Tennessee, has issued a recall on one lot each of its sildenafil 100 mg tablets and trazodone 100 mg tablets due to a packaging “mix-up” in which both drugs were filled into the same bottle. According to AvKARE, the error occurred at a third-party bottle filling facility.
Bayer has announced that all of its products will have 100 percent green packaging by 2030. This means all of the company’s over-the-counter (OTC) drugs and supplements such as pain, allergy and cold medications, and vitamins will have brand packaging that is 100 percent recyclable or reusable in less than ten years’ time.
This initiative focuses on enhancing infrastructure to support the clinical and commercial-scale final assembly and packaging of drug-device combination products, emphasizing advanced drug delivery systems, particularly injectable formats. Operations at the first phase of the plant are scheduled to begin in Q3 2025.
Employee retention and motivation is a challenge that all lifescience companies face. Lifescience companies often have to follow a complex regulatory framework that is associated with high risks, which is why maintaining corporate compliance is essential. Training and Development Opportunities.
This partnership provides SOLABS’ LifeSciences clients with exciting capabilities in the areas of reporting and analytics. MONTREAL, QC, December 09, 2020 /24-7PressRelease/ — SOLABS enters into a partnership with NexGen Analytics. NexGen has primarily focused on the LifeSciences industry.
From packaging errors and contaminants to serious adverse effects, there are many reasons why products in the lifesciences industry get recalled. Here’s a look at some of the latest drug and medical device recalls.
• BugBiome wins a business support package worth over £100,000, including one year of free lab space at Discovery Park and £50,000 investment from Discovery Park Ventures• BioMavericks awarded the wildcard prize as voted for by the audience at the GIANT Health Healthcare Investment Show on 5th December
The thermal packaging company not only bolsters its APAC presenceit also grows its presence in the lifesciences temperature-monitoring logistics sector.
The team also talked about Sagent Pharmaceutical’s voluntary recall of several lots of its injectable seizure medication levetiracetam due to potential loss of sterility because of a container closure issue on the vials it comes packaged in. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode.
PWC predicts deal volumes to resemble prior years with the effect of the US Inflation Reduction Act on pricing better understood and less uncertainty surrounding business conditions, according to an article entitled Pharmaceutical & LifeSciences: US Deals 2023 Outlook published on the company’s website.
BOSTON–(BUSINESS WIRE)–Packaging Technology Group, Inc (PTG), a leading provider of thermal packaging solutions for the biopharmaceutical and lifesciences sector, responds to the global pandemic with the launch of its off-the-shelf line of pre-qualified shippers, including an earth-friendly alternative.
As a vertically integrated company, SHL Medical prides itself on being an end-to-end partner, offering in-house capabilities at every stage – from design, development and production to final assembly, labelling and packaging. Discover why global lifesciences businesses are choosing this thriving region.
Torbett said in a statement: “As the government focuses on its growth agenda, it should look to lifesciences and make the most of this funding to unlock the future potential of our sector. As companies begin to seek approval from the regulator for new COVID-19 vaccines, it’s critical that we get the roll out right.
A plant in Wales manufacturing the AstraZeneca COVID-19 vaccine was evacuated on the advice of the authorities today after it was sent a suspicious package. Wockhardt UK in Wrexham this morning received a suspicious package. There are no reports of any injuries and as yet no word whether the package was dangerous.
“As we continue to grow and meet demand, we will remain focused on providing broader and more integrated workflow solutions within the biopharma, cell & gene therapy, and related lifesciences end markets.”.
Two-Plasmid Packaging System for Recombinant Adeno-Associated Virus. Cytiva and the Drop logo are trademarks of LifeSciences IP Holdings Corp. ELEVECTA is a trademark of Global LifeSciences Solutions USA LLC or an affiliate doing business as Cytiva. 1] BioNews. Hemophilia News Today. link] [2] Tang Q, et al.
Additionally, the site will be able to prepare and package 70 million fill and finish vaccine doses per year for commercial distribution. The company says that the cGMP facility will be able to produce drug formulations for up to 160 million doses of mRNA vaccine every year. In addition to a $39.8
This is an exciting opportunity to join pharmaphorum, contributing to our revenue targets, meeting new clients and supporting the development and launch of new offerings within the company’s leading international lifescience industry publications.
AvKARE, a generics pharmaceutical manufacturer based in Pulaski, Tennessee, has issued a recall on one lot each of its sildenafil 100 mg tablets and trazodone 100 mg tablets due to a packaging “mix-up” in which both drugs were filled into the same bottle. According to AvKARE, the error occurred at a third-party bottle filling facility.
The expansion will include a new 30,000-square-foot building that will be able to produce 160 million doses of an mRNA vaccine per year, and up to 70 million prepared and packaged fill finish doses for commercial distribution annually. Additional production would be performed at other facilities for final packaging.
The whole package should be available, the Chinese package, for countries’ regulatory authorities to license the product in the last quarter of this year,” Morgon states. Pierre has over 35 years of experience in the global lifescience industry in specialty care, vaccines and immunotherapy and has been CEO of several start-ups.
As the competitive landscape for skilled professionals intensifies, companies are re-evaluating their health benefits packages to include innovative treatments that go beyond traditional healthcare offerings. Many job seekers are thus factoring the availability of GLP-1 drug coverage into their decisions about where to work.
Administration of a product that is not sterile may cause serious systemic infections that could pose to be life-threatening. The levetiracetam injection (USP 500 mg per 5 mL) is packaged in a single-dose 5 mL vial. Levetiracetam injection is used for the treatment of certain types of seizures.
She focuses on news relating to the food industry and writes blogs on recruitment and HR in the lifesciences. Ayesha Rashid, PhD , is a senior lifescience journalist and webinar moderator at Xtalks where she covers the latest news stories in the industry.
The lifesciences industry has an important role in the Irish economy, with sectors such as biologics booming across the country. With an attractive corporate tax rate and the youngest workforce in the EU, Ireland continues to be a popular destination for lifescience companies to settle.
This includes drug substance and drug product development, clinical trial logistics, product labeling, supply chain management, commercial packaging, and more. Retrieved from [link] LifeScience Leader. Scalability and Flexibility The ability to scale production to meet clinical and commercial needs is vital. 2022, September 8).
The pharmaceutical and lifesciences services provider recently revealed its latest partnership with Moderna, collaborating for renting of COD services across the US. Jon Sewell is a Technical Manager at Origin Pharma Packaging, responsible for the Aseptic Filling Program and Special Projects. About the author.
Provided as a cloud or on-premise solution, PRISYM 360 is designed specifically to address the unique complexities of medical device, clinical trial and pharmaceutical labeling and packaging artwork. About PRISYM ID.
It will also produce policy documents and information packages for patients, doctors and senior management in companies, Other workstreams could include computational strategies to make such simulations more powerful and efficient, new curricula to educate the workforce on the development and use of the technologies.
Dear Pharma and LifeScience Colleagues, Thank you for your interest in our virtual round table on ESG, regulation and rebates in the health industry. 24 November 2021 or 25 November 2021. Alongside these issues, the health sector is also facing major regulatory challenges.
Xenoview is a 129 Xe gas blend; it is packaged in a dose delivery bag and thus can be inhaled by a patient during a single breath hold MRI procedure (10 to 15 seconds long). After hyperpolarization, it is packaged into a dosage delivery bag.
Package Installation. Package Installation - Sandbox. Chayanika is a content writer and guest contributor to Cloudbyz, specializing in well-researched content for the healthcare and lifesciences industries. Package Installation. Package Installation - Sandbox. Global Site Solutions Summit. Internal Seminar.
Compounded semaglutide products, unlike the US Food and Drug Administration (FDA)-approved ones, can vary widely in strength and packaging, making it easy for mistakes to happen. These issues primarily stem from patients and healthcare providers miscalculating or incorrectly administering the drug.
Driven by advancements in technology, these complex therapeutics have already made waves in lifesciences, providing revolutionary treatment options in oncology, immune conditions and rare diseases. Being highly technology-focused, lifescience companies have an important responsibility to be among the first to adopt these solutions”.
Jackie Mulryne, Partner, is a member of the LifeSciences practice group, and provides regulatory, policy, and compliance advice to clients in the pharmaceutical, medical technology, cosmetics, and foods sectors. About the authors.
Underrepresentation is multifactorial, so concerted efforts from lifescience companies are required to address inequitable healthcare. As a Non-Clinical Assessor at MHRA he assessed non-clinical data packages for new and generic medicines. About the interviewees.
The investment package includes £200 million ($268 million) to enable researchers to better access NHS data through what the government calls Trusted Research Environments and digital clinical trial services.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content